Not applicableLooking for participantsNCT02912143What this trial is testingGerman Pediatric Hemophilia Research DatabaseWho this might be right forHemophilia AHemophilia BChildren+1 more Goethe University 800
Testing effectiveness (Phase 2)Study completedNCT02552121What this trial is testingTisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid TumorsWho this might be right forOvary CancerCervix CancerEndometrium Cancer+4 more Seagen Inc. 33
Early research (Phase 1)Looking for participantsNCT04662580What this trial is testingARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate CancerWho this might be right forMetastatic Prostate Cancer Janssen Research & Development, LLC 183
Testing effectiveness (Phase 2)Looking for participantsNCT07136779What this trial is testingFirst-in-Human Trial of VBC101 in Participants With Advanced Solid Tumor MalignanciesWho this might be right forParticipants With Advanced Solid Tumor Malignancies VelaVigo Bio Inc 310
Large-scale testing (Phase 3)Looking for participantsNCT04877288What this trial is testingEvaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive MedicationsWho this might be right forRenal Allograft Recipients Bristol-Myers Squibb 102
Early research (Phase 1)Looking for participantsNCT07082920What this trial is testingJNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate CancerWho this might be right forProstatic Neoplasms Janssen Research & Development, LLC 140
Testing effectiveness (Phase 2)Study completedNCT02988817What this trial is testingEnapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid TumorsWho this might be right forOvarian CancerCervical CancerEndometrial Cancer+5 more Genmab 306
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07258407What this trial is testingA Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate CancerWho this might be right forMetastatic Castration-Resistant Prostatic Cancer T.O.A.D. Oncology SA 180
Testing effectiveness (Phase 2)Study completedNCT03380377What this trial is testingClazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney TransplantWho this might be right forAntibody-mediated RejectionKidney Transplant; ComplicationsTransplant Glomerulopathy+3 more Stanley Jordan, MD 10
Not applicableUnknownNCT05606302What this trial is testingA Multi-center Clinical Study of Drug Antibody and Precision Transfusion in ChinaWho this might be right forDrug-specific Antibodies Nanfang Hospital, Southern Medical University 14,000
Large-scale testing (Phase 3)Study completedNCT02171130What this trial is testingClinical Usability of Intranasal Glucagon in Treatment of HypoglycemiaWho this might be right forHypoglycemiaDiabetes MellitusDrug-Specific Antibodies Eli Lilly and Company 129
Testing effectiveness (Phase 2)WithdrawnNCT05582694What this trial is testingA Trial of Anti-CD4 Antibody UB-421 in Combination With Optimized Background Antiretroviral Therapy in Patients With Multi-Drug Resistant HIV-1 InfectionWho this might be right forMulti-Drug Resistant Hiv-1 InfectionHIV-1 Infection National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT02001623What this trial is testingTisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid TumorsWho this might be right forOvary CancerCervix CancerEndometrium Cancer+5 more Seagen Inc. 195
Early research (Phase 1)Study completedNCT01414296What this trial is testingExtended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate CancerWho this might be right forProstate Cancer Progenics Pharmaceuticals, Inc. 10
Early research (Phase 1)Study completedNCT01414283What this trial is testingProstate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate CancerWho this might be right forProstate Cancer Progenics Pharmaceuticals, Inc. 52
Early research (Phase 1)Looking for participantsNCT06805825What this trial is testingThe c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-KitWho this might be right forGastrointestinal Stromal TumorsSmall-cell Lung CancerAdenoid Cystic Carcinoma+4 more Novelty Nobility, Inc. 67
Not applicableStudy completedNCT06565364What this trial is testingImmunogenicity and Thrombotic Potential of Circulating Protamine-heparin Complexes in Cardiac Surgery PatientsWho this might be right forThrombocytopeniaAntibodies Drug Specific Medical University of Vienna 160
Large-scale testing (Phase 3)Study completedNCT01959334What this trial is testingEvaluate the Immunogenicity of a Novel Glucagon FormulationWho this might be right forDrug-specific AntibodiesDiabetes Mellitus Eli Lilly and Company 75
Post-approval studies (Phase 4)Study completedNCT04370145What this trial is testingAntibiotics Treatment of Cholangitis Post-Kasai PortoenterostomyWho this might be right forCholangitis, Secondary BiliaryTreatment ComplianceAntibodies Drug Specific Tongji Hospital 160
Testing effectiveness (Phase 2)Looking for participantsNCT06525298What this trial is testingEIS-12656 as Single Agent and in Combination in Patients With Specified Solid TumorsWho this might be right forAdvanced Solid TumorHomologous Recombination DeficiencyHRR Deficiency Eisbach Bio GmbH 144